ArticleThe Journal of allergy and clinical immunology2019

Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition.

Yael Gernez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.